Biomerica, Inc.

$2.35-1.26%($-0.03)
TickerSpark Score
50/100
Mixed
85
Valuation
20
Profitability
15
Growth
80
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMRA research report →

52-Week Range18% of range
Low $1.87
Current $2.35
High $4.60

Companywww.biomerica.com

Biomerica, Inc. , a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations.

CEO
Zackary S. Irani
IPO
1984
Employees
64
HQ
Irvine, CA, US

Price Chart

-35.44% · this period
$4.14$3.03$1.92May 20Nov 18May 20

Valuation

Market Cap
$7.26M
P/E
-1.69
P/S
1.68
P/B
2.13
EV/EBITDA
-1.58
Div Yield
0.00%

Profitability

Gross Margin
4.32%
Op Margin
-123.74%
Net Margin
-96.49%
ROE
-98.14%
ROIC
-152.51%

Growth & Income

Revenue
$5.31M · -1.92%
Net Income
$-4,973,000 · 16.81%
EPS
$-2.16 · -500.00%
Op Income
$-5,137,000
FCF YoY
29.18%

Performance & Tape

52W High
$4.60
52W Low
$1.87
50D MA
$2.16
200D MA
$2.53
Beta
0.28
Avg Volume
22.82K

Get TickerSpark's AI analysis on BMRA

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Dec 12, 25Chin Ericother22,500
Dec 12, 25Lu Garyother40,000
Dec 12, 25Irani Zackary S.other52,500
Dec 12, 25BARBIERI ALLENother30,000
Dec 12, 25MOATAZEDI DAVIDother20,000
Dec 12, 25Gary M. Huffother20,000
Jun 4, 25Chin Ericother0
Dec 13, 24Emerson Janeother85,000
Dec 13, 24Irani Zackary S.other250,000
Dec 13, 24BARBIERI ALLENother110,000

Our BMRA Coverage

We haven't published any research on BMRA yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate BMRA Report →

Similar Companies